[Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials].

Van Cutsem, E

[Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials]. [electronic resource] - Bulletin du cancer Dec 1998 - 33-7 p. digital

Publication Type: Journal Article; Review

0007-4551


Adenocarcinoma--drug therapy
Adult
Aged
Antimetabolites, Antineoplastic--therapeutic use
Antineoplastic Agents, Phytogenic--adverse effects
Camptothecin--adverse effects
Clinical Trials, Phase II as Topic
Colorectal Neoplasms--drug therapy
Disease-Free Survival
Drug Resistance, Neoplasm
Enzyme Inhibitors--adverse effects
Europe
Female
Fluorouracil--therapeutic use
Humans
Irinotecan
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Proteins--antagonists & inhibitors
Palliative Care
Remission Induction
Salvage Therapy
Topoisomerase I Inhibitors
Treatment Outcome
United States